Compare RAND & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RAND | PIII |
|---|---|---|
| Founded | 1969 | 2015 |
| Country | United States | United States |
| Employees | N/A | 320 |
| Industry | Finance: Consumer Services | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 31.8M | 37.5M |
| IPO Year | 1996 | N/A |
| Metric | RAND | PIII |
|---|---|---|
| Price | $10.28 | $10.51 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 3.6K | ★ 239.4K |
| Earning Date | 05-06-2026 | 05-14-2026 |
| Dividend Yield | ★ 10.83% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $7.67 |
| Revenue Next Year | N/A | $2.36 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $10.00 | $1.52 |
| 52 Week High | $20.00 | $16.89 |
| Indicator | RAND | PIII |
|---|---|---|
| Relative Strength Index (RSI) | 42.97 | 50.61 |
| Support Level | $10.03 | $9.80 |
| Resistance Level | $11.15 | $11.30 |
| Average True Range (ATR) | 0.15 | 1.51 |
| MACD | 0.00 | -0.54 |
| Stochastic Oscillator | 34.99 | 21.54 |
Rand Capital Corp is a closed-end, externally managed, non-diversified investment company. Its investment objective is to generate current income and, when possible, complement its current income with capital appreciation by focusing its debt and related equity investments in privately-held, lower middle market companies with committed and experienced managements in a broad variety of industries. It predominantly invests in higher-yielding debt instruments.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.